General Information of the Compound
| Compound ID |
CP0834204
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(4-{2-[4-(4-Chlorophenyl)-piperazin-1-yl]-ethyl}-piperidine-1-sulfonyl)-isoquinoline hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H32Cl2N4O2S
|
||||||||||||||||||
| Molecular Weight |
535.541
|
||||||||||||||||||
| Canonical SMILES |
Cl.O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccc(Cl)cc3)CC2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H31ClN4O2S.ClH/c27-23-5-7-24(8-6-23)30-17-15-29(16-18-30)12-9-21-10-13-31(14-11-21)34(32,33)26-20-28-19-22-3-1-2-4-25(22)26;/h1-8,19-21H,9-18H2;1H
Show/Hide
|
||||||||||||||||||
| InChIKey |
FUMFBOOKIXYDBC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7